BAL PHARMA LTD. - 524824 - Intimation Of Webinar
We would like to bring to your notice that the Company is hosting a webinar on the 'strategies for quality growth', at 4.00 P.M IST on 21.09.2022. The Company will be represented by its Managing Director Mr.Shailesh Siroya. BAL PHARMA LTD. - 524824 - E-Voting Results & Scrutinizers Report
We are submitting to the exchange the results of the remote e-voting for 35th Annual General Meeting of the Company held on 19.09.2022, along with the copy of scrutinizers report. The aforesaid reports are also available on our website i.e www.balpharma.com. BAL PHARMA LTD. - 524824 - Announcement under Regulation 30 (LODR)-Meeting Updates
Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting to the exchange the business transacted at the 35th Annual General Meeting of the Company conducted through audio visual means, on 19.09.2022. BAL PHARMA LTD. - 524824 - Announcement under Regulation 30 (LODR)-Investor Presentation
We are submitting the revised Investor presentation on the performance of the Company for the quarter ended 30.06.2022. BAL PHARMA LTD. - 524824 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation for Q1 FY 23 BAL PHARMA LTD. - 524824 - Compliance With Regulation 46 And 62 Of SEBI(LODR) Regulations.
We are submitting to the exchange disclosure regarding functional website of the Company, as per Regulation 46 and 62 of SEBI(LODR) Regulations,2015. BAL PHARMA LTD. - 524824 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement''s on Notice for 35th Annual General Meeting, e-voting and book closure. BAL PHARMA LTD. - 524824 - Reg. 34 (1) Annual Report.
Sub : Notice of 35th Annual General Meeting and submission of Annual Report for Financial Year 2021-2022 Ref : Regulation 34 of SEBI (LODR) Regulations,2015. As already informed to the exchanges, 35th Annual General Meeting of the Company is scheduled to be held on 19th September 2022 at 11.30 A.M through audio visual means. Notice along with the details of the business to be transacted at the meeting and audited financial statements of the Company for the F.Y ended 30.03.2022 together with the reports of Directors and auditors there on is being dispatched to our shareholders through electronic form. A Copy of the unabridged annual report of the Company for the financial year ended 31.03.2022 is enclosed for submission to the exchanges. Annual report for F.Y 2021.22 is also available on our website i.e www.balpharma.com BAL PHARMA LTD. - 524824 - Announcement under Regulation 30 (LODR)-Newspaper Publication
We are submitting to the exchanges news paper advertisements of the Unaudited financial results of the Company for the quarter ended 30.06.2022, published in Snajayvani ( Kannada ) and Financial Express ( English ) newspapers on 13.08.2022. BAL PHARMA LTD. - 524824 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press release on Un-audited financial results for the quarter ended 30.06.2022.